Thursday, January 1, 2009

Pharmaceutical Industry - Non U.S. stories:

1. Other News To Note.
   Alnylam Pharmaceuticals Inc., of Cambridge, Mass., has published data in the journal Oligonucleotides demonstrating robust silencing of an endogenous oligodendrocyte gene with small interfering RNAs when administered by direct delivery to the central nervous system in both rats and nonhuman primates. [BIOWORLD Today]

2. Other News To Note.
   Acura Pharmaceuticals Inc., of Palatine, Ill., said King Pharmaceuticals Inc., of Bristol, Tenn., exercised its option to license a fourth immediate-release opioid analgesic product candidate using Acura's Aversion technology, which is designed to deter common methods of prescription drug misuse and abuse, and ... [BIOWORLD Today]